Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-16-035178
Filing Date
2016-07-12
Accepted
2016-07-12 17:21:56
Documents
60
Period of Report
2016-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A atrn20160630_8ka.htm 8-K/A 794025
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 588100
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 295280
10 schulman.jpg GRAPHIC 376408
  Complete submission text file 0001437749-16-035178.txt   5641301

Data Files

Seq Description Document Type Size
4 EXHIBIT 101.INS atrn-20151231.xml EX-101.INS 746434
5 EXHIBIT 101.SCH atrn-20151231.xsd EX-101.SCH 49661
6 EXHIBIT 101.CAL atrn-20151231_cal.xml EX-101.CAL 32830
7 EXHIBIT 101.DEF atrn-20151231_def.xml EX-101.DEF 371010
8 EXHIBIT 101.LAB atrn-20151231_lab.xml EX-101.LAB 285001
9 EXHIBIT 101.PRE atrn-20151231_pre.xml EX-101.PRE 383819
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 000-51353 | Film No.: 161764538
SIC: 7389 Services-Business Services, NEC